Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)

Abstract

About

This paper, published in 1950, received 351 indexed citations. Written by Michael J. Duffy, Nadia Harbeck, R. Molina, Andrea Nicolini, Elżbieta Senkus and Fátima Cardoso covering the research area of Cancer Research, Oncology and Genetics. It is primarily cited by scholars working on Cancer Research (186 citations), Oncology (159 citations) and Molecular Biology (121 citations). Published in European Journal of Cancer.

In The Last Decade

doi.org/10.1016/j.ejca.2017.01.017 →

Countries where authors are citing Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)

Since Specialization

Citations

This map shows the geographic impact of Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM) more than expected).

Fields of papers citing Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM). Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1016/j.ejca.2017.01.017.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Cognitive and behavioural flexibility: neural mechanisms and clinical considerations Breakdown of academic impact, for the paper Anode-Electrolyte Interfaces in Secondary Magnesium Batteries Breakdown of academic impact, for the paper Combating VR sickness through subtle dynamic field-of-view modification Breakdown of academic impact, for the paper Cellularity of rat adipose tissue: effects of growth, starvation, and obesity Breakdown of academic impact, for the paper Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect Breakdown of academic impact, for the paper A linear sequence of extant families and genera of lycophytes and ferns Breakdown of academic impact, for the paper CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors Breakdown of academic impact, for the paper Influence of traversing crack on chloride diffusion into concrete